Omeros (OMER) Long-Term Debt Issuances (2011 - 2020)
Omeros' (OMER) quarterly Long-Term Debt Issuances came in at $225.0 million in Q3 2020, up 35.99% quarter-over-quarter from $165.4 million in Q4 2018.
Omeros (OMER) Long-Term Debt Issuances (2011 - 2020) Analysis & Trends
Omeros has disclosed Long-Term Debt Issuances across 6 years of filings, most recently posting $225.0 million for Q3 2020.
- Long-Term Debt Issuances for Q3 2020 came in at $225.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $390.4 million (changed N/A YoY), and the FY2020 annual result was $225.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances came in at $225.0 million for Q3 2020 at Omeros, up from $165.4 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $225.0 million in Q3 2020 to a low of -$19.9 million in Q4 2016.
- The 3-year median for Long-Term Debt Issuances is $165.4 million (2018), against an average of $123.5 million.
- Peak annual rise in Long-Term Debt Issuances reached 139.73% in 2016, while the deepest fall reached 139.73% in 2016.
- Omeros' Long-Term Debt Issuances stood at -$19.9 million in 2016, then soared by 932.91% to $165.4 million in 2018, then surged by 35.99% to $225.0 million in 2020.
- The last three Long-Term Debt Issuances figures came in at $225.0 million (Q3 2020), $165.4 million (Q4 2018), and -$19.9 million (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Omeros | 628.56 Mn | 493.24 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 225.00 Mn |
| Sep 30, 2020 | 225.00 Mn |
| Dec 31, 2018 | 165.45 Mn |
| Dec 31, 2018 | 165.45 Mn |
| Dec 31, 2016 | -19.86 Mn |
| Dec 31, 2016 | -19.86 Mn |
| Dec 31, 2015 | 50.00 Mn |
| Dec 31, 2015 | 50.00 Mn |
| Dec 31, 2014 | 19.30 Mn |
| Dec 31, 2014 | 19.30 Mn |
| Jun 30, 2014 | -1,000.00 |
| Jun 30, 2014 | -1,000.00 |
| Mar 31, 2014 | 12.70 Mn |
| Mar 31, 2014 | 12.70 Mn |
| Mar 31, 2011 | 9.94 Mn |
| Mar 31, 2011 | 9.94 Mn |